Fulgent Genetics to Participate in Piper Sandler’s 34th Annual Healthcare Conference
November 17 2022 - 4:05PM
Business Wire
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the
“Company”), a technology-based genetic testing and therapeutics
company focused on transforming patient care in oncology,
infectious and rare diseases, reproductive health, and pathology,
today announced that members of its management team are scheduled
to participate in the Piper Sandler 34th Annual Healthcare
Conference on Wednesday, November 30, 2022.
These representatives of the company will conduct a presentation
beginning at approximately 10:00 a.m. Eastern Time (7:00 a.m.
Pacific Time).
A live webcast of the session will be available on the Investor
Relations section of the Fulgent Genetics website at
ir.fulgentgenetics.com. A replay of the webcast will be accessible
at the same location beginning approximately one hour following the
completion of the event.
About Fulgent
Fulgent is a technology-based genetic testing and therapeutics
company focused on transforming patient care in oncology,
infectious and rare diseases, reproductive health, and pathology.
Its proprietary technology platform for genetics has created a
broad, flexible test menu and the ability to continually expand and
improve its proprietary genetic reference library while maintaining
accessible pricing, high accuracy, and competitive turnaround
times. Fulgent’s therapeutics business is fully focused on
developing drug candidates for treating a broad range of cancers
using a novel nanoencapsulation and targeted therapy platform
designed to improve the therapeutic window and pharmacokinetic
profile of new and existing cancer drugs. The company aims to
transform from a genomic diagnostic business into a fully
integrated precision medicine company focused on oncology.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221117006047/en/
Investor Relations Contacts: The Blueshirt Group Melanie
Solomon, melanie@blueshirtgroup.com
Fulgent Genetics (NASDAQ:FLGT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Fulgent Genetics (NASDAQ:FLGT)
Historical Stock Chart
From Apr 2023 to Apr 2024